We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCS icon
701
Marcus Corp
MCS
$845M
$3.09M 0.01%
78,316
-20,500
-21% -$847K
SITC icon
702
SITE Centers
SITC
$152M
$3.09M 0.01%
358,080
-386,078
-52% -$3.63M
BALL icon
703
Ball Corp
BALL
$16.3B
$3.09M 0.01%
67,206
+17,200
+34% +$804K
GME icon
704
GameStop
GME
$10.9B
$3.07M 0.01%
973,200
+732,800
+305% +$2.56M
VALE icon
705
Vale
VALE
$61.1B
$3.06M 0.01%
231,691
+3,011
+1% +$43K
GTE icon
706
Gran Tierra Energy
GTE
$378M
$3.04M 0.01%
140,135
-7,480
-5% -$215K
WPS
707
DELISTED
iShares International Developed Property ETF
WPS
$3.01M 0.01%
87,380
HAL icon
708
Halliburton
HAL
$29.3B
$3.01M 0.01%
113,065
-38,616
-25% -$1.3M
ZNGA
709
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$3M 0.01%
763,600
-2,020,200
-73% -$7.64M
ICPT
710
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3M 0.01%
29,755
XLRN
711
DELISTED
Acceleron Pharma
XLRN
$2.99M 0.01%
68,735
+29,515
+75% +$1.47M
SIMO icon
712
Silicon Motion
SIMO
$8.2B
$2.99M 0.01%
86,582
FNV icon
713
Franco-Nevada
FNV
$50.8B
$2.98M 0.01%
42,426
-48,751
-53% -$3.26M
GMF icon
714
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$421M
$2.96M 0.01%
33,769
FRT icon
715
Federal Realty Investment Trust
FRT
$9.89B
$2.96M 0.01%
25,060
+1,500
+6% +$188K
ENVA icon
716
Enova International
ENVA
$4.29B
$2.95M 0.01%
151,400
-9,000
-6% -$205K
EFA icon
717
iShares MSCI EAFE ETF
EFA
$78.2B
$2.92M 0.01%
49,766
-5,700
-10% -$356K
MEDP icon
718
Medpace
MEDP
$17.3B
$2.92M 0.01%
55,200
+28,700
+108% +$1.58M
MSI icon
719
Motorola Solutions
MSI
$77.2B
$2.92M 0.01%
25,386
XMLV icon
720
Invesco S&P MidCap Low Volatility ETF
XMLV
$729M
$2.92M 0.01%
65,740
+4,110
+7% +$192K
FSP
721
Franklin Street Properties
FSP
$34.4M
$2.89M 0.01%
464,300
-55,300
-11% -$406K
DBS
722
DELISTED
Invesco DB Silver Fund
DBS
$2.89M 0.01%
125,880
-14,500
-10% -$319K
HLT icon
723
Hilton Worldwide
HLT
$69.4B
$2.89M 0.01%
40,277
+16,255
+68% +$1.17M
ALL icon
724
Allstate
ALL
$64.7B
$2.89M 0.01%
34,965
-2,974
-8% -$267K
CRI icon
725
Carter's
CRI
$1.08B
$2.87M 0.01%
35,100
-74,300
-68% -$6.75M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.